Literature DB >> 9036943

Biochemical analysis of p120/130: a protein-tyrosine kinase substrate restricted to T and myeloid cells.

A J da Silva1, J M Rosenfield, I Mueller, A Bouton, H Hirai, C E Rudd.   

Abstract

T cell activation is mediated by a cascade of intracellular events involving protein-tyrosine kinases and their substrates. p56(lck) and p59(fyn) are protein-tyrosine kinases that associate with CD4/CD8 and the TCRzeta/CD3 complex, respectively. We previously reported the appearance of a protein doublet at 120 and 130 kDa that preferentially associates with p59(fyn) and undergoes tyrosine phosphorylation upon receptor ligation. In this paper, we demonstrate that p120/130 is a novel protein that is restricted in expression to T cells, thymocytes and myeloid cells. Internal peptide sequencing and immunoblotting using an anti-p120/130 antisera showed that p120/130 is a unique protein that is distinct from p130(cas) and p125(cbl). By contrast, p120 and p130 shared similar peptide patterns and are structurally related. Alkaline phosphatase digestion of precipitates showed that they are not related due to phosphorylation. p120/130 was found to associate constitutively with a 55-kDa protein of unknown identity, but which is distinct from p56(lck) and Shc. p120/130 also undergoes a unique kinetics of phosphorylation and associates with the Ag receptor in response to TCR ligation. In keeping with the association with p59(fyn), T cells from p59(fyn)-negative mice exhibit reduced phosphorylation of the protein. p120/130 therefore represents a novel TCR associated intracellular molecule with potential to play a role in T cell signaling.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9036943

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  Positive and negative adaptors in T-cell signalling.

Authors:  Beverley Wilkinson; Hongyan Wang; Christopher E Rudd
Journal:  Immunology       Date:  2004-04       Impact factor: 7.397

Review 2.  Integrin signalling and function in immune cells.

Authors:  Yanbo Zhang; Hongyan Wang
Journal:  Immunology       Date:  2012-04       Impact factor: 7.397

3.  T-cell signaling and immunopathologies.

Authors:  Christopher E Rudd
Journal:  Semin Immunopathol       Date:  2010-06       Impact factor: 9.623

4.  Cloning of a novel T-cell protein FYB that binds FYN and SH2-domain-containing leukocyte protein 76 and modulates interleukin 2 production.

Authors:  A J da Silva; Z Li; C de Vera; E Canto; P Findell; C E Rudd
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

Review 5.  Immunopathologies linked to integrin signalling.

Authors:  Hongyan Wang; Daina Lim; Christopher E Rudd
Journal:  Semin Immunopathol       Date:  2010-03-10       Impact factor: 9.623

6.  Adaptor FYB (Fyn-binding protein) regulates integrin-mediated adhesion and mediator release: differential involvement of the FYB SH3 domain.

Authors:  L Geng; S Pfister; S K Kraeft; C E Rudd
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

Review 7.  SKAP-55, SKAP-55-related and ADAP adaptors modulate integrin-mediated immune-cell adhesion.

Authors:  Hongyan Wang; Christopher E Rudd
Journal:  Trends Cell Biol       Date:  2008-08-28       Impact factor: 20.808

8.  SLP-76-ADAP adaptor module regulates LFA-1 mediated costimulation and T cell motility.

Authors:  Hongyan Wang; Bin Wei; Georges Bismuth; Christopher E Rudd
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-15       Impact factor: 11.205

9.  Functional defects of SKAP-55-deficient T cells identify a regulatory role for the adaptor in LFA-1 adhesion.

Authors:  Hongyan Wang; Hebin Liu; Yuning Lu; Matt Lovatt; Bin Wei; Christopher E Rudd
Journal:  Mol Cell Biol       Date:  2007-07-23       Impact factor: 4.272

10.  FYB (FYN binding protein) serves as a binding partner for lymphoid protein and FYN kinase substrate SKAP55 and a SKAP55-related protein in T cells.

Authors:  J Liu; H Kang; M Raab; A J da Silva; S K Kraeft; C E Rudd
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.